Making Stem Cells
Compatible
with Everyone
Editing Stem Cells to Cure Disease
rAAV
Universal Cells creates Universal Donor Stem Cells by editing the genes required for immune recognition. By using our recombinant Adeno-Associated Virus (rAAV) technology, we design and manufacture stem cell-based products that can be used as off-the-shelf cell therapies.
One Universal Stem Cell Bank
Universal Donor Cells are pluripotent and can differentiate into various cell types that can be used to treat a vast number of diseases. Learn more about the Universal Cells’ pipeline and partnerships.
Latest News
Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology
Tokyo, October 19, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Universal Cells, Inc. (CEO: Claudia Mitchell, “Universal Cells”) today announced that Astellas Institute for Regenerative Medicine (“AIRM”) and [...]
Cell and Gene Therapy Catapult Licenses iPSC Line to Universal Cells to assist in the Development of Universal Donor Cell Line
Universal Cells to utilise CGT Catapult’s induced Pluripotent Stem Cells to create universally accepted cells for research and commercial use London, UK, 5 October 2017 – The Cell and Gene Therapy Catapult (CGT Catapult) today [...]
BlueRock Therapeutics and Universal Cells Enter Collaboration and License Agreement to Generate Gene-Edited iPS Cell Lines
CAMBRIDGE, MA and SEATTLE, WA, October 3, 2017－BlueRock Therapeutics and Universal Cells Inc. today announced that they have entered into a collaboration and license agreement to create induced pluripotent stem (iPS) cell lines useful for [...]